Literature DB >> 22493340

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

Lowell E Schnipper1, Thomas J Smith, Derek Raghavan, Douglas W Blayney, Patricia A Ganz, Therese Marie Mulvey, Dana S Wollins.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22493340     DOI： 10.1200/JCO.2012.42.8375

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  197 in total

1.  Preparing for success with comparative effectiveness research.

Authors:  Thomas G Roberts
Journal:  Oncologist       Date:  2013-06

2.  Evolution of the Quality Oncology Practice Initiative supportive care quality measures portfolio and conformance at a Veterans Affairs medical center.

Authors:  Ryan D Nipp; Michael J Kelley; Christina D Williams; Arif H Kamal
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

3.  Does value mean quality? The payer's perspective.

Authors:  Jennifer L Malin
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

4.  Five-year risk of interval-invasive second breast cancer.

Authors:  Janie M Lee; Diana S M Buist; Nehmat Houssami; Emily C Dowling; Elkan F Halpern; G Scott Gazelle; Constance D Lehman; Louise M Henderson; Rebecca A Hubbard
Journal:  J Natl Cancer Inst       Date:  2015-04-22       Impact factor: 13.506

5.  Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study.

Authors:  Maria Rita Migliorino; Antonio Santo; Giampiero Romano; Diego Cortinovis; Domenico Galetta; Oscar Alabiso; Giacomo Cartenì; Sabrina Vari; Gianpiero Fasola; Antonio Pazzola; Dario Giuffrida; Alberto Zaniboni; Alberto Caprioli; Flavia Longo; Valentina Acciai; Filippo de Marinis
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-18       Impact factor: 4.553

6.  Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.

Authors:  Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Grace C Hillyer; Jim C Hu; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

7.  Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.

Authors:  Hisaharu Shikata; Yoshihiro Yakushijin; Jun Yamanouchi; Taichi Azuma; Masaki Yasukawa
Journal:  Int J Clin Oncol       Date:  2013-02-05       Impact factor: 3.402

8.  Associations between cancer-related information seeking and receiving PET imaging for routine cancer surveillance--an analysis of longitudinal survey data.

Authors:  Andy S L Tan; Laura Gibson; Hanna M Zafar; Stacy W Gray; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-18       Impact factor: 4.254

9.  Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project.

Authors:  Erin E Hahn; Patricia A Ganz; Michelle E Melisko; John P Pierce; Marlene von Friederichs-Fitzwater; Karen T Lane; Robert A Hiatt
Journal:  J Cancer Surviv       Date:  2013-03-15       Impact factor: 4.442

10.  What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists.

Authors:  Masanori Mori; Chikako Shimizu; Asao Ogawa; Takuji Okusaka; Saran Yoshida; Tatsuya Morita
Journal:  Support Care Cancer       Date:  2018-08-25       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.